+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vivo and in vitro models of demyelinating diseases. XII. Persistence and expression of corona JHM virus functions in RN2-2 Schwannoma cells during latency



In vivo and in vitro models of demyelinating diseases. XII. Persistence and expression of corona JHM virus functions in RN2-2 Schwannoma cells during latency



Virus Research 3(3): 245-261



The coronavirus JHMV persistently infects rat Schwannoma cells RN2-2 at 32.5 degrees C and enters a host-imposed reversible, latent state at 39.5 degrees C. JHMV can remain up to 20 days in the latent state and about 14 days before the cultures lose the capacity to resume virus production upon return to 32.5 degrees C. Although persistently and latently infected RN2-2 cells display resistance to superinfection by a heterologous agent VSV, these cells do not release detectable soluble mediators (e.g., interferon) of the antiviral state. Nevertheless, RN2-2 cells are competent to synthesize and release interferon when treated with the appropriate inducers. These observations suggest that interferon does not play any role or may not be the major factor in the control of latency in the Schwannoma cell. Hybridization with virus-specific cDNAs shows that all viral mRNAs are present during latency and that viral mRNAs are present in the polysomes of infected cells at 39.5 degrees C. Western immunoblotting with hybridoma antibodies demonstrates that viral specific proteins are produced at the restrictive temperature. These results suggest that despite the absence of production of infectious virus at 39.5 degrees C, there is active transcription and translation into virus-specified products.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040394888

Download citation: RISBibTeXText

PMID: 3000100


Related references

In vivo and in vitro models of demyelinating diseases. II. Persistence and host-regulated thermosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses. Virology 88(2): 325-337, 1978

In vivo and in vitro models of demyelinating diseases: tropism of the JHM strain of murine hepatitis virus for cells of glial origin. Cell 12(2): 553-560, 1977

In vivo and in vitro models of demyelinating diseases. IV. Isolation of Hallé measles virus-specific RNA from BGMK cells and preparation of complementary DNA. Virology 102(2): 327-338, 1980

In vivo and in vitro models of demyelinating disease 10. a schwannoma l 2 somatic cell hybrid persistently yielding high titers of mouse hepatitis virus strain jhm. Virus Research 1(6): 477-488, 1984

In vivo and in vitro models of demyelinating disease X. A Schwannoma-L-2 somatic cell hybrid persistently yielding high titres of mouse hepatitis virus strain Jhm. Virus Research 1(6): 477-487, 1984

In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats. Archives of Neurology 37(8): 478-484, 1980

In vivo and in vitro models of demyelinating diseases--VIII: Genetic, immunologic and cellular influences on JHM virus infection of rats. Advances in Experimental Medicine and Biology 173: 279-298, 1984

In vivo and in vitro models of demyelinating diseases. V. Comparison of the assembly of mouse hepatitis virus, strain JHM, in two murine cell lines. Intervirology 18(3): 135-146, 1982

Lack of correlation between the expression of herpes simplex virus type 1 (HSV-1) glycoprotein C and both the maintenance of persistence in vitro and the capacity to establish latency in vivo. Microbiologica 11(2): 101-110, 1988

In vivo and in vitro models of demyelinating diseases. XXIV. The infectious process in cyclosporin A treated Wistar Lewis rats inoculated with JHM virus. Microbial Pathogenesis 6(1): 7, 1989

In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes. Journal of Virology 61(12): 3795-3803, 1987

Cellular HIV-1 latency in vitro and in vivo Expanding molecular models for proviral persistence. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 179, 1993

In vivo and in vitro Models of Demyelinating Diseases. Intervirology 18(3): 135-146, 1982

In vivo and in vitro models of demyelinating diseases. Virus Research 3(3): 245-261, 1985

In vivo and in vitro models of demyelinating diseases. Advances in Experimental Medicine and Biology 142: 271-286, 1981